Armatinib

armatinin? (exact generic name not provided)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Armatinib, covering 2023-04-05 to 2023-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer [Phase 3]